GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » EBITDA Margin %

Forward Pharma A/S (Forward Pharma A/S) EBITDA Margin % : 0.00% (As of Jun. 2022)


View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Forward Pharma A/S's EBITDA for the six months ended in Jun. 2022 was $0.30 Mil. Forward Pharma A/S's Revenue for the six months ended in Jun. 2022 was $0.00 Mil. Therefore, Forward Pharma A/S's EBITDA margin for the quarter that ended in Jun. 2022 was 0.00%.


Forward Pharma A/S EBITDA Margin % Historical Data

The historical data trend for Forward Pharma A/S's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S EBITDA Margin % Chart

Forward Pharma A/S Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.01 - - - -

Forward Pharma A/S Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Forward Pharma A/S's EBITDA Margin %

For the Biotechnology subindustry, Forward Pharma A/S's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forward Pharma A/S's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forward Pharma A/S's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Forward Pharma A/S's EBITDA Margin % falls into.



Forward Pharma A/S EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Forward Pharma A/S's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-3.874/0
= %

Forward Pharma A/S's EBITDA Margin % for the quarter that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=0.304/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forward Pharma A/S  (OTCPK:FWPAY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Forward Pharma A/S EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Forward Pharma A/S's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Forward Pharma A/S (Forward Pharma A/S) Business Description

Traded in Other Exchanges
N/A
Address
Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100
Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.